ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new ...
We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
AbbVie and Simcere Zaiming have announced an option-to-license agreement for the development of an investigational drug candidate, SIM0500.
Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...
CEO of ImmunoPrecise Antibodies. "By harnessing AI and rethinking drug discovery from the ground up, we are not just improving the process—we are fundamentally changing what’s possible.
Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...